# A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab

> **NCT06169527** · — · ACTIVE_NOT_RECRUITING · sponsor: **Sanofi** · enrollment: 303 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT06169527
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-28
- **Primary completion:** 2028-05-10
- **Final completion:** 2028-05-10
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2025-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06169527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06169527, "A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06169527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*